股本结构
单位：万股
| 公告日期 | 2024-05-13 | 2024-05-13 | 2024-03-27 | 2024-03-04 | 2024-02-13 | 2023-12-04 |
|---|---|---|---|---|---|---|
| 证券总股本 | 692.56 | 691.62 | 691.62 | 656.40 | 406.40 | 12191.88 |
| 普通股本 | 692.56 | 691.62 | 691.62 | 656.40 | 406.40 | 12191.88 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-05-03 | 2024-03-31 | 2024-03-21 | 2024-03-05 | 2024-02-14 | 2023-11-27 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-05-13 | 692.56 | 未披露 | 定期报告 | 2024-05-03 |
| 2024-05-13 | 691.62 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Proceeds from issuance of common stock and warrants through underwritten offering, net of issuance cost
Proceeds from issuance of common stock to collaboration partners and licensees
Proceeds from issuance of common stock through ATM facility, net of issuance cost
Restricted stock units vested
Issuance of common stock under employee stock purchase plan
|
2024-03-31 |
| 2024-03-27 | 691.62 | 未披露 | 定期报告 | 2024-03-21 |
| 2024-03-04 | 656.40 | 未披露 |
更多>>
Common stock offered 2,500,000 shares by the company
|
2024-03-05 |
| 2024-02-13 | 406.40 | 未披露 |
更多>>
On February 13, 2024, Precision BioSciences, Inc. (the “Company”) effected a 1-for-30 reverse stock split of its common stock (the “Reverse Stock Split”).
|
2024-02-14 |
| 2023-12-04 | 12191.88 | 未披露 | 定期报告 | 2023-11-27 |
| 2023-12-04 | 12089.68 | 未披露 | 定期报告 | 2023-11-15 |
| 2023-11-07 | 11893.52 | 未披露 | 定期报告 | 2023-11-01 |
| 2023-11-07 | 11568.00 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock under employee stock purchase plan
Proceeds from issuance of common stock, net of issuance cost
|
2023-09-30 |
| 2023-08-04 | 11507.05 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Proceeds from issuance of common stock, net of issuance cost
Restricted stock units vested
|
2023-06-30 |
| 2023-05-09 | 11379.33 | 未披露 | 定期报告 | 2023-05-02 |
| 2023-05-09 | 11233.94 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Stock option exercises
Issuance of common stock under employee stock purchase plan
Proceeds from issuance of common stock, net of issuance cost
Restricted stock units vested
|
2023-03-31 |
| 2023-03-23 | 11169.64 | 未披露 | 定期报告 | 2023-03-09 |
| 2023-03-09 | 11129.57 | 未披露 | 定期报告 | 2023-03-01 |
| 2023-03-09 | 11096.40 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Stock option exercises
Issuance of common stock under employee stock purchase plan
Net proceeds from issuance of common stock
Restricted stock units vested
Issuance of common stock to collaboration partners
|
2022-12-31 |
| 2022-11-08 | 11095.90 | 未披露 | 定期报告 | 2022-11-03 |
| 2022-11-08 | 11093.47 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Stock option exercises
Issuance of common stock under employee stock purchase plan
Restricted stock units vested
|
2022-09-30 |
| 2022-08-08 | 11081.80 | 未披露 | 定期报告 | 2022-08-03 |
| 2022-08-08 | 11079.50 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Stock option exercises
Proceeds from issuance of common stock, net of issuance cost
Issuance of common stock to collaboration partners
Restricted stock units vested
|
2022-06-30 |
| 2022-06-24 | 9774.58 | 未披露 |
更多>>
1.Common stock offered by 35,971,224 shares
2.The number of shares of common stock to be outstanding after this offering is based on 61,774,571 shares of common stock outstanding as of March 31, 2022
|
2022-06-24 |
| 2022-05-09 | 6217.64 | 未披露 | 定期报告 | 2022-05-03 |
| 2022-05-09 | 6177.46 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Stock option exercises
Issuance of common stock under employee stock purchase plan
Proceeds from issuance of common stock, net of issuance cost
|
2022-03-31 |
| 2022-03-15 | 6103.83 | 未披露 | 定期报告 | 2022-03-08 |
| 2022-03-15 | 6090.21 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Stock option exercises
Issuance of common stock under employee stock purchase plan
Issuance of common stock to collaboration partners
Proceeds from issuance of common stock, net of issuance cost
|
2021-12-31 |
| 2021-11-10 | 6076.73 | 未披露 | 定期报告 | 2021-11-03 |
| 2021-11-10 | 6008.15 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Stock option exercises
Issuance of common stock under employee stock purchase plan
Proceeds from issuance of common stock, net of issuance cost
|
2021-09-30 |
| 2021-08-12 | 5957.78 | 未披露 | 定期报告 | 2021-08-03 |
| 2021-08-12 | 5928.30 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Stock option exercises
Proceeds from issuance of common stock, net of issuance cost
|
2021-06-30 |
| 2021-05-13 | 5748.03 | 未披露 | 定期报告 | 2021-05-06 |
| 2021-05-13 | 5722.24 | 未披露 |
更多>>
From January 1, 2021 To March 31, 2021
Stock option exercises
Issuance of common stock under employee stock purchase plan
Issuance of common stock to collaboration partners
|
2021-03-31 |
| 2021-04-12 | 5714.15 | 未披露 | 定期报告 | 2021-03-15 |
| 2021-03-18 | 5698.62 | 未披露 | 定期报告 | 2021-03-02 |
| 2021-03-18 | 5269.27 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Stock option exercises
Issuance of common stock under employee stock purchase plan
|
2020-12-31 |
| 2020-11-10 | 5248.05 | 未披露 | 定期报告 | 2020-11-04 |
| 2020-11-10 | 5247.50 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Stock option exercises
Issuance of common stock under employee stock purchase plan
|
2020-09-30 |
| 2020-08-13 | 5234.48 | 未披露 | 定期报告 | 2020-08-06 |
| 2020-08-13 | 5216.84 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Stock option exercises
|
2020-06-30 |
| 2020-05-15 | 5186.14 | 未披露 | 定期报告 | 2020-05-08 |
| 2020-05-15 | 5144.29 | 未披露 |
更多>>
From January 1, 2020 to March 31, 2020
Stock option exercises
Issuance of common stock under employee stock purchase plan
|
2020-03-31 |
| 2020-03-27 | 5141.49 | 未披露 | 定期报告 | 2020-03-23 |
| 2020-03-10 | 5139.98 | 未披露 | 定期报告 | 2020-03-02 |
| 2020-03-10 | 5115.52 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Conversion of convertible preferred stock into common stock upon initial public offering
Issuance of common stock upon conversion of convertible notes payable
Issuance of common stock in initial public offering, net of discounts and issuance costs
Stock option exercises
|
2019-12-31 |
| 2019-11-12 | 5078.73 | 未披露 | 定期报告 | 2019-11-06 |
| 2019-11-12 | 5065.97 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Stock option exercises
|
2019-09-30 |
| 2019-08-14 | 5063.09 | 未披露 | 定期报告 | 2019-08-08 |
| 2019-08-14 | 5059.05 | 未披露 |
更多>>
from March 31, 2019 to June 30, 2019
Conversion of convertible preferred stock into common stock upon initial public offering
Issuance of common stock upon conversion of convertible notes
Issuance of common stock in initial public offering, net of discounts and issuance costs
Stock option exercises
|
2019-06-30 |
| 2019-04-29 | 5036.17 | 未披露 | 定期报告 | 2019-04-26 |
| 2019-04-29 | 1605.26 | 4760.61 |
更多>>
From January 1, 2019 to March 31, 2019
Stock option exercises
|
2019-03-31 |
| 2019-03-28 | 4902.90 | 未披露 |
更多>>
1. Common stock offered 7,900,000 shares
2. The number of shares of our common stock to be outstanding after this offering is based on 15,906,645 shares of our common stock outstanding as of December 31, 2018
3. A 1 -for- 2.134686 reverse stock split of our common stock effected on March 15, 2019
|
2019-03-28 |
| 2019-03-01 | 3395.58 | 未披露 | 定期报告 | 2018-12-31 |
From December 31, 2023 to March 31, 2024
Proceeds from issuance of common stock and warrants through underwritten offering, net of issuance cost
Proceeds from issuance of common stock to collaboration partners and licensees
Proceeds from issuance of common stock through ATM facility, net of issuance cost
Restricted stock units vested
Issuance of common stock under employee stock purchase plan
Common stock offered 2,500,000 shares by the company
On February 13, 2024, Precision BioSciences, Inc. (the “Company”) effected a 1-for-30 reverse stock split of its common stock (the “Reverse Stock Split”).
From June 30, 2023 to September 30, 2023
Issuance of common stock under employee stock purchase plan
Proceeds from issuance of common stock, net of issuance cost
From March 31, 2023 to June 30, 2023
Proceeds from issuance of common stock, net of issuance cost
Restricted stock units vested
From December 31, 2022 to March 31, 2023
Stock option exercises
Issuance of common stock under employee stock purchase plan
Proceeds from issuance of common stock, net of issuance cost
Restricted stock units vested
From December 31, 2021 to December 31, 2022
Stock option exercises
Issuance of common stock under employee stock purchase plan
Net proceeds from issuance of common stock
Restricted stock units vested
Issuance of common stock to collaboration partners
From June 30, 2022 to September 30, 2022
Stock option exercises
Issuance of common stock under employee stock purchase plan
Restricted stock units vested
From March 31, 2022 to June 30, 2022
Stock option exercises
Proceeds from issuance of common stock, net of issuance cost
Issuance of common stock to collaboration partners
Restricted stock units vested
1.Common stock offered by 35,971,224 shares
2.The number of shares of common stock to be outstanding after this offering is based on 61,774,571 shares of common stock outstanding as of March 31, 2022
From January 1, 2022 to March 31, 2022
Stock option exercises
Issuance of common stock under employee stock purchase plan
Proceeds from issuance of common stock, net of issuance cost
From December 31, 2020 to December 31, 2021
Stock option exercises
Issuance of common stock under employee stock purchase plan
Issuance of common stock to collaboration partners
Proceeds from issuance of common stock, net of issuance cost
From June 30, 2021 to September 30, 2021
Stock option exercises
Issuance of common stock under employee stock purchase plan
Proceeds from issuance of common stock, net of issuance cost
From March 31, 2021 to June 30, 2021
Stock option exercises
Proceeds from issuance of common stock, net of issuance cost
From January 1, 2021 To March 31, 2021
Stock option exercises
Issuance of common stock under employee stock purchase plan
Issuance of common stock to collaboration partners
From December 31, 2019 to December 31, 2020
Stock option exercises
Issuance of common stock under employee stock purchase plan
From June 30, 2020 to September 30, 2020
Stock option exercises
Issuance of common stock under employee stock purchase plan
From March 31, 2020 to June 30, 2020
Stock option exercises
From January 1, 2020 to March 31, 2020
Stock option exercises
Issuance of common stock under employee stock purchase plan
from December 31, 2018 to December 31, 2019
Conversion of convertible preferred stock into common stock upon initial public offering
Issuance of common stock upon conversion of convertible notes payable
Issuance of common stock in initial public offering, net of discounts and issuance costs
Stock option exercises
from June 30, 2019 to September 30, 2019
Stock option exercises
from March 31, 2019 to June 30, 2019
Conversion of convertible preferred stock into common stock upon initial public offering
Issuance of common stock upon conversion of convertible notes
Issuance of common stock in initial public offering, net of discounts and issuance costs
Stock option exercises
From January 1, 2019 to March 31, 2019
Stock option exercises
1. Common stock offered 7,900,000 shares
2. The number of shares of our common stock to be outstanding after this offering is based on 15,906,645 shares of our common stock outstanding as of December 31, 2018
3. A 1 -for- 2.134686 reverse stock split of our common stock effected on March 15, 2019